JP2022028975A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2022028975A5 JP2022028975A5 JP2021202092A JP2021202092A JP2022028975A5 JP 2022028975 A5 JP2022028975 A5 JP 2022028975A5 JP 2021202092 A JP2021202092 A JP 2021202092A JP 2021202092 A JP2021202092 A JP 2021202092A JP 2022028975 A5 JP2022028975 A5 JP 2022028975A5
- Authority
- JP
- Japan
- Prior art keywords
- group
- salt
- ophthalmic composition
- chondroitin sulfate
- pranoprofen
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 150000003839 salts Chemical class 0.000 claims 6
- SQDAZGGFXASXDW-UHFFFAOYSA-N 5-bromo-2-(trifluoromethoxy)pyridine Chemical compound FC(F)(F)OC1=CC=C(Br)C=N1 SQDAZGGFXASXDW-UHFFFAOYSA-N 0.000 claims 4
- 229920001287 Chondroitin sulfate Polymers 0.000 claims 4
- 229940059329 chondroitin sulfate Drugs 0.000 claims 4
- TVQZAMVBTVNYLA-UHFFFAOYSA-N Pranoprofen Chemical compound C1=CC=C2CC3=CC(C(C(O)=O)C)=CC=C3OC2=N1 TVQZAMVBTVNYLA-UHFFFAOYSA-N 0.000 claims 3
- 229960003101 pranoprofen Drugs 0.000 claims 3
- ZAKOWWREFLAJOT-CEFNRUSXSA-N D-alpha-tocopherylacetate Chemical compound CC(=O)OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-CEFNRUSXSA-N 0.000 claims 2
- BYJAVTDNIXVSPW-UHFFFAOYSA-N tetryzoline Chemical compound N1CCN=C1C1C2=CC=CC=C2CCC1 BYJAVTDNIXVSPW-UHFFFAOYSA-N 0.000 claims 2
- 229940042585 tocopherol acetate Drugs 0.000 claims 2
- SPSPIUSUWPLVKD-UHFFFAOYSA-N 2,3-dibutyl-6-methylphenol Chemical compound CCCCC1=CC=C(C)C(O)=C1CCCC SPSPIUSUWPLVKD-UHFFFAOYSA-N 0.000 claims 1
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 claims 1
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 claims 1
- 239000002253 acid Substances 0.000 claims 1
- 229940121363 anti-inflammatory agent Drugs 0.000 claims 1
- 239000002260 anti-inflammatory agent Substances 0.000 claims 1
- 239000000043 antiallergic agent Substances 0.000 claims 1
- 235000003704 aspartic acid Nutrition 0.000 claims 1
- OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 claims 1
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 claims 1
- CZBZUDVBLSSABA-UHFFFAOYSA-N butylated hydroxyanisole Chemical compound COC1=CC=C(O)C(C(C)(C)C)=C1.COC1=CC=C(O)C=C1C(C)(C)C CZBZUDVBLSSABA-UHFFFAOYSA-N 0.000 claims 1
- 235000010354 butylated hydroxytoluene Nutrition 0.000 claims 1
- 150000001875 compounds Chemical class 0.000 claims 1
- 229940079593 drug Drugs 0.000 claims 1
- 239000003814 drug Substances 0.000 claims 1
- 230000035807 sensation Effects 0.000 claims 1
- XOAAWQZATWQOTB-UHFFFAOYSA-N taurine Chemical compound NCCS(O)(=O)=O XOAAWQZATWQOTB-UHFFFAOYSA-N 0.000 claims 1
- 229960000337 tetryzoline Drugs 0.000 claims 1
- 229940088594 vitamin Drugs 0.000 claims 1
- 239000011782 vitamin Substances 0.000 claims 1
- 229930003231 vitamin Natural products 0.000 claims 1
- 235000013343 vitamin Nutrition 0.000 claims 1
Priority Applications (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2022057713A JP2022079633A (ja) | 2015-10-15 | 2022-03-30 | 異物感改善用眼科組成物 |
| JP2023076355A JP2023093761A (ja) | 2015-10-15 | 2023-05-02 | 異物感改善用眼科組成物 |
| JP2024215348A JP2025023354A (ja) | 2015-10-15 | 2024-12-10 | 異物感改善用眼科組成物 |
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2015203994 | 2015-10-15 | ||
| JP2015203994 | 2015-10-15 | ||
| JP2015256235 | 2015-12-28 | ||
| JP2015256235 | 2015-12-28 | ||
| JP2016203154A JP2017119669A (ja) | 2015-10-15 | 2016-10-14 | 異物感改善用眼科組成物 |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016203154A Division JP2017119669A (ja) | 2015-10-15 | 2016-10-14 | 異物感改善用眼科組成物 |
Related Child Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022057713A Division JP2022079633A (ja) | 2015-10-15 | 2022-03-30 | 異物感改善用眼科組成物 |
| JP2023076355A Division JP2023093761A (ja) | 2015-10-15 | 2023-05-02 | 異物感改善用眼科組成物 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2022028975A JP2022028975A (ja) | 2022-02-16 |
| JP2022028975A5 true JP2022028975A5 (enExample) | 2022-04-08 |
Family
ID=59271468
Family Applications (5)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016203154A Withdrawn JP2017119669A (ja) | 2015-10-15 | 2016-10-14 | 異物感改善用眼科組成物 |
| JP2021202092A Withdrawn JP2022028975A (ja) | 2015-10-15 | 2021-12-13 | 異物感改善用眼科組成物 |
| JP2022057713A Pending JP2022079633A (ja) | 2015-10-15 | 2022-03-30 | 異物感改善用眼科組成物 |
| JP2023076355A Pending JP2023093761A (ja) | 2015-10-15 | 2023-05-02 | 異物感改善用眼科組成物 |
| JP2024215348A Pending JP2025023354A (ja) | 2015-10-15 | 2024-12-10 | 異物感改善用眼科組成物 |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016203154A Withdrawn JP2017119669A (ja) | 2015-10-15 | 2016-10-14 | 異物感改善用眼科組成物 |
Family Applications After (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022057713A Pending JP2022079633A (ja) | 2015-10-15 | 2022-03-30 | 異物感改善用眼科組成物 |
| JP2023076355A Pending JP2023093761A (ja) | 2015-10-15 | 2023-05-02 | 異物感改善用眼科組成物 |
| JP2024215348A Pending JP2025023354A (ja) | 2015-10-15 | 2024-12-10 | 異物感改善用眼科組成物 |
Country Status (1)
| Country | Link |
|---|---|
| JP (5) | JP2017119669A (enExample) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP6687781B1 (ja) * | 2019-03-08 | 2020-04-28 | ロート製薬株式会社 | 刺激感が抑制された眼科組成物 |
| WO2020184479A1 (ja) * | 2019-03-08 | 2020-09-17 | ロート製薬株式会社 | 刺激感が抑制された眼科組成物 |
| JP2023022567A (ja) * | 2021-08-03 | 2023-02-15 | 小林製薬株式会社 | 洗眼組成物 |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP3021312B2 (ja) * | 1994-03-15 | 2000-03-15 | 千寿製薬株式会社 | プラノプロフェンの安定化方法および安定なプラノプロフェン水性液剤 |
| ITMI981586A1 (it) * | 1998-07-10 | 2000-01-10 | Giorgio Panin | Vitamina e e suoi esteri per l'uso nel trattamento topico di patologie delle mucose |
| JP2005239682A (ja) * | 2004-02-27 | 2005-09-08 | Taisho Pharmaceut Co Ltd | 眼科用剤 |
| JP4919666B2 (ja) * | 2005-01-26 | 2012-04-18 | ロート製薬株式会社 | プラノプロフェン含有組成物 |
| JP2007169232A (ja) * | 2005-12-26 | 2007-07-05 | Lion Corp | 眼科用組成物 |
| JP6009141B2 (ja) * | 2009-10-09 | 2016-10-19 | ロート製薬株式会社 | 水性組成物 |
| WO2013099861A1 (ja) * | 2011-12-27 | 2013-07-04 | 千寿製薬株式会社 | ジブチルヒドロキシトルエン含有製剤及びジブチルヒドロキシトルエンの安定化方法 |
| JP6148957B2 (ja) * | 2012-10-02 | 2017-06-14 | ロート製薬株式会社 | プラノプロフェン含有水性組成物 |
| JP2014111587A (ja) * | 2012-11-06 | 2014-06-19 | Rohto Pharmaceut Co Ltd | 眼科用アレルギー予防剤 |
| JP6315755B2 (ja) * | 2013-10-02 | 2018-04-25 | ロート製薬株式会社 | 異物感緩和点眼剤 |
| TW201540292A (zh) * | 2014-03-10 | 2015-11-01 | Senju Pharma Co | 二丁基羥基甲苯的穩定化方法（二） |
-
2016
- 2016-10-14 JP JP2016203154A patent/JP2017119669A/ja not_active Withdrawn
-
2021
- 2021-12-13 JP JP2021202092A patent/JP2022028975A/ja not_active Withdrawn
-
2022
- 2022-03-30 JP JP2022057713A patent/JP2022079633A/ja active Pending
-
2023
- 2023-05-02 JP JP2023076355A patent/JP2023093761A/ja active Pending
-
2024
- 2024-12-10 JP JP2024215348A patent/JP2025023354A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2022028975A5 (enExample) | ||
| FI3426285T3 (fi) | Pegyloidun urikaasin formulaatioita ja annoksia | |
| JP2015057436A5 (enExample) | ||
| CN102497864B (zh) | 用于预防或治疗由化疗诱发的疼痛的σ配体 | |
| JP2015527402A5 (enExample) | ||
| HRP20151350T1 (hr) | Neuroprotekcija kod demijelinizacijskih bolesti | |
| JP2009102342A5 (enExample) | ||
| RU2013121788A (ru) | Ингибиторы репликации вич | |
| BRPI0413756A (pt) | composto, métodos para tratar ou evitar espasticidade ou um sintoma de espasticidade, doença de refluxo gastro-esofágico, vìcio em droga, vìcio em ou abuso de álcool, ou vìcio em ou abuso de nicotina, e tosse ou êmese em um paciente, e, composição farmacêutica | |
| JP2011201907A5 (enExample) | ||
| SE9904413D0 (sv) | Comminuted form | |
| MX2020008173A (es) | Combinacion de un agente antimuscarinico o de uno anticolinergico y acido lipoico, y sus usos. | |
| WO2001030749B1 (en) | Novel compounds | |
| IL292770A (en) | Formulations and doses of pegylated uricase | |
| JP2016510747A5 (enExample) | ||
| CL2021001018A1 (es) | Formulación basada en ciclodextrina de un inhibidor de bcl-2 | |
| MX2023001572A (es) | Formas farmaceuticas sólidas de palbociclib. | |
| JP2020536098A5 (enExample) | ||
| CN115607545B (zh) | 依达拉奉在自闭症谱系障碍治疗中的应用 | |
| JP2013518061A5 (enExample) | ||
| SE9904412D0 (sv) | Comminuted form | |
| WO2012058269A3 (en) | Methods of treating cancer and other diseases | |
| WO2007042983A3 (en) | Fluridone as an anti-inflammatory agent | |
| JP2007519701A5 (enExample) | ||
| EA201591218A1 (ru) | Способы и композиции для введения оксибутинина |